Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,045 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Use of vaccinia virus vectors to study the synthesis, intracellular localization, and action of the human immunodeficiency virus trans-activator protein.
Falkner FG, Fuerst TR, Moss B. Falkner FG, et al. Among authors: moss b. Virology. 1988 Jun;164(2):450-7. doi: 10.1016/0042-6822(88)90559-4. Virology. 1988. PMID: 2835862
Inhibition of vaccinia virus late protein synthesis by isatin-beta-thiosemicarbazone: characterization and in vitro translation of viral mRNA.
Cooper JA, Moss B, Katz E. Cooper JA, et al. Among authors: moss b. Virology. 1979 Jul 30;96(2):381-92. doi: 10.1016/0042-6822(79)90096-5. Virology. 1979. PMID: 462812 No abstract available.
Abortive transcription products of vaccinia virus are guanylylated, methylated, and polyadenylylated.
Gershowitz A, Moss B. Gershowitz A, et al. Among authors: moss b. J Virol. 1979 Sep;31(3):849-53. doi: 10.1128/JVI.31.3.849-853.1979. J Virol. 1979. PMID: 513196 Free PMC article.
Methylated 5'-terminal sequences of vaccinia virus mRNA species made in vivo at early and late times after infection.
Boone RF, Moss B. Boone RF, et al. Among authors: moss b. Virology. 1977 Jun 1;79(1):67-80. doi: 10.1016/0042-6822(77)90335-x. Virology. 1977. PMID: 867823 No abstract available.
Formation of the guanylylated and methylated 5'-terminus of vaccinia virus mRNA.
Moss B, Gershowitz A, Wei CM, Boone R. Moss B, et al. Virology. 1976 Jul 15;72(2):341-51. doi: 10.1016/0042-6822(76)90163-x. Virology. 1976. PMID: 948865 No abstract available.
Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein.
Schnierle BS, Gershon PD, Moss B. Schnierle BS, et al. Among authors: moss b. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2897-901. doi: 10.1073/pnas.89.7.2897. Proc Natl Acad Sci U S A. 1992. PMID: 1313572 Free PMC article.
Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA, Couture L, Elroy-Stein O, Ragheb J, Moss B, Anderson WF. Morgan RA, et al. Among authors: moss b. Nucleic Acids Res. 1992 Mar 25;20(6):1293-9. doi: 10.1093/nar/20.6.1293. Nucleic Acids Res. 1992. PMID: 1313966 Free PMC article.
The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2.
Davies MV, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ. Davies MV, et al. Among authors: moss b. J Virol. 1992 Apr;66(4):1943-50. doi: 10.1128/JVI.66.4.1943-1950.1992. J Virol. 1992. PMID: 1347793 Free PMC article.
Transition from rapid processive to slow nonprocessive polyadenylation by vaccinia virus poly(A) polymerase catalytic subunit is regulated by the net length of the poly(A) tail.
Gershon PD, Moss B. Gershon PD, et al. Among authors: moss b. Genes Dev. 1992 Aug;6(8):1575-86. doi: 10.1101/gad.6.8.1575. Genes Dev. 1992. PMID: 1353739
Vaccinia and other poxvirus expression vectors.
Moss B. Moss B. Curr Opin Biotechnol. 1992 Oct;3(5):518-22. doi: 10.1016/0958-1669(92)90080-3. Curr Opin Biotechnol. 1992. PMID: 1368937 Review.
1,045 results
Jump to page